Heart Matters

A recent review article on advances in heart failure treatment from the Cleveland Clinic is a good reminder of the physiology behind traditional heart failure pharmacotherapy and a primer for emerging therapies – two of which are currently available in Australia, ivabradine (Coralan) and eplerenone (Inspra).

Being up to date with review articles such as this can really help when communicating with our cardiology colleagues.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s